FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
Issues Related to HealthcareTests and TestingFDA WatchTreatmentsAre Clinical Trial Participants Really That Diverse?Jonathan Block
Ask The PharmacistIssues Related to HealthcareDeprescribing: What Is It and How Can You Benefit From It?Dave Walker, RPh
Issues Related to HealthcareHealth BuzzSafety Isn’t Always First When the FDA Approves Medical DevicesDiane Archer
Issues Related to HealthcareHealth PulseHow Patients Could Be Harmed If Kratom is BannedJonathan Block
Issues Related to HealthcareAdverse Events From Cosmetics Increase, Prompting Calls for More RegulationJonathan Block
Issues Related to HealthcareTests and TestingFDA WatchTreatmentsFDADo Clinical Trials Discriminate Against Women?Sarah Smedley
Issues Related to HealthcareHealth PulseFDAHas Government Shutdown Impacted Drug Safety?Jonathan Block
Issues Related to HealthcareNewsFDAQuick HitsQuick Hits: FDA identified 10 Drugs With Safety Issues and MoreAlanna McCatty
